Tokyo Smoke’s Yonge St. Location Now Open

After much anticipation, Tokyo Smoke’s Toronto dispensary is now open at 333 Yonge St. Entrepreneur and winner of one of the city’s five cannabis licenses, Colin Campbell, partnered with the brand to open a location in the old record shop near the corner of Yonge and Dundas. - The DailyHive

Image via The DailyHive

Health Canada Announces $600K Funding For Awareness Campaign

A new three-year, $600,000 micro-grant fund has been launched by Health Canada under its Substance Use and Addictions Program, to support community-led education efforts to inform the public about the health facts of cannabis use and vaping.

“Ensuring that Canadians are aware of the health effects of cannabis use and vaping is key to helping to reduce the harms associated with these activities. I am pleased that our Government is offering these micro-grants to help Canadians take action within their communities. Armed with factual information from a source they trust, Canadians can make informed decisions and lead healthier lives,” said Minister of Health Ginette Petitpas Taylor in a press release. - The GrowthOp

Retailers Struggle To Keep CBD On Shelves

While Canada has been experiencing a shortage of cannabis in general, there’s been one product that has been particularly hard to keep on the shelves, CBD. The extract most commonly used in oil form has grown in popularity in recent years for its numerous health benefits, and lack of the “high” commonly associated with cannabis.

"I don't think the licensed producers really realized how popular CBD was, so there's none available, really," said Krystian Wetulani, founder of City Cannabis Co. in Vancouver. - CTV news

First Time Cannabis Use Up After Legalization

In the first three months of 2018, about 330,000 Canadians said they'd tried cannabis for the first time. A year later, it was up to 650,000.

"One of the things … unique with this survey is the number of respondents who said they're using for the first time. So they started, in this case, in the post-legalization period," said Michelle Rotermann, a senior analyst in Statistics Canada's health analysis division. - CBC News


The Grow-Off Launching It’s First Canadian Cannabis Competition

Biotech company Qualis Cannabis Corporation has announced it plans to hold a Canadian edition of The Grow-Off, a competition that tests cannabis-growing skills. Competitors in the Grow-Off are all challenged to raise the best crop from the same genetic starting line.

“This is the first competition of its kind in Canada. We can’t wait to showcase Canadian growing expertise to the world,” said Kevin Puloski, CEO of Qualis Cannabis in a press release. - The GrowthOp

American MSO Cansortium Wins Canadian Cannabis Production License

Cansortium Inc., a leading Florida-based multi-state operator (“MSO”) medical cannabis company with a mission to deliver the highest standards of cannabis care from nursery to lab to shelf, announced that Health Canada, pursuant to the Cannabis Act, has granted to Cansortium Canada, an indirect wholly-owned subsidiary of the Company, a cannabis cultivation, processing, and medical sales license.

“After more than a year and a half of dedicated and diligent work on the process, securing our Canadian license is a significant milestone on our path toward becoming a truly global cannabis company.” - Jose Hidalgo, Cansortium Founder & CEO . - New Cannabis Ventures

Acreage shareholder plans to vote against ‘unbelievably lopsided’ Canopy deal

Marcato Capital Management, which owns about three percent of U.S. cannabis operator Acreage Holdings, plans to vote against the company’s proposed deal with Canadian marijuana giant Canopy Growth, describing the unique tie-up as a “value destructive transaction and not in the best interests of shareholders.”

Shareholders will decide on the deal in June while a circular to vote on the deal is expected to be distributed to Acreage shareholders in the next few weeks. An Acreage spokesperson told BNN Bloomberg the company remains confident the deal will happen despite some shareholders’ concerns. - BNN Bloomberg